Journal of Emergencies, Trauma, and Shock
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
Users online:784   Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size   


 
 Table of Contents    
CASE REPORT  
Year : 2012  |  Volume : 5  |  Issue : 1  |  Page : 87-89
Humoral hypercalcemic crisis in a pregnant woman with uterine leiomyoma


Department of Medicine, Hamad General Hospital, Doha, Qatar

Click here for correspondence address and email

Date of Submission08-Jan-2011
Date of Acceptance04-Oct-2011
Date of Web Publication22-Feb-2012
 

   Abstract 

We report a case of parathyroid hormone-related protein-mediated hypercalcemic crisis in a 36-year-old pregnant woman, who was admitted to women hospital with recurrent vomiting and epigastric pain. She was diagnosed with uterine fibroid since the first month of her pregnancy, but the pregnancy had been uneventful. Serum calcium was 4.8 mmol/l, while parathyroid hormone was low. Hypercalcemia was attributed to humoral hypercalcemia associated with uterine fibroid as other causes of hypercalcemia were excluded.

Keywords: Humoral hypercalcemia, hypercalcemic crisis, uterine fibroid

How to cite this article:
Rahil A, Khan FY. Humoral hypercalcemic crisis in a pregnant woman with uterine leiomyoma. J Emerg Trauma Shock 2012;5:87-9

How to cite this URL:
Rahil A, Khan FY. Humoral hypercalcemic crisis in a pregnant woman with uterine leiomyoma. J Emerg Trauma Shock [serial online] 2012 [cited 2020 Jul 12];5:87-9. Available from: http://www.onlinejets.org/text.asp?2012/5/1/87/93093



   Introduction Top


Severe hypercalcemia during pregnancy is a rare but potentially life-threatening condition that poses a significant danger to mother and baby; [1],[2] in general, hypercalcemia during pregnancy may arise from several different pathological conditions. The most common etiology is primary hyperparathyroidism. Other causes include hyperthyroidism, immobilization, vitamin D, and vitamin A overdose, familial hypocalciuric hypercalcemia, diuretic phase of acute renal failure, chronic renal failure, thiazide diuretics, sarcoidosis or other granulomatous diseases, milk-alkali syndrome, and Addison's disease. [2] Although rare, hypercalcemia may also develop in pregnant women due to parathyroid hormone-related protein (PTH-rP) producing malignant tumors (humoral hypercalcemia of malignancy). Hypercalcemia due to high serum levels of PTH-rP in the setting of benign disease is extremely rare. We report a 36-year-old pregnant woman with uterine fibroid who developed hypercalcemic crisis at her third trimester.


   Case Report Top


A 36-year-old Kenyan woman, primigravida at 34-week spontaneous pregnancy, admitted to women hospital on April 12, 2008, with recurrent vomiting and epigastric pain. She was diagnosed with uterine fibroid since the first month of her pregnancy, but the pregnancy had been uneventful. She had history of weight loss (10 kg), no change in bowel habits, no hematemesis or rectal bleeding, and no history of hematuria or passing stones. The patient was using iron tablets; otherwise her medical history was unremarkable. On examination, she looked ill, markedly dehydrated, and drowsy. Her blood pressure was 126/76 mmHg, pulse rate 94 min−1 , respiratory rate 30 min−1 , and temperature 36.6°C; she had no lymphadenopathy, no thyromegaly, and no edema. Abdominal examination showed a uterus size of 40 weeks and tender epigastric area. Neurological examination showed a drowsy and hypotonic lady with brisk deep tendon reflexes. There was no obvious focal neurological sign. Planter reflexes were down-going. Chest and cardiovascular systems were unremarkable.

The findings of initial investigations were as follows: hemoglobin (Hb) 8.7 g/dl, WBCs 7000 μl−1 , platelets 445 000 μl−1 ; and ESR 109 mm/h. Peripheral blood smear showed toxic granulation of WBCs. Blood chemistry: BUN 4.4 mmol/l, creatinine 59 μmol/l, HCO 3 22 mmol/l, Na 138 mmol/l, Ca 4.8 mmol/l (normal: 2.1-2.6), uric acid 508 μmol/l, lactic acid 1.2 mmol/l, and phosphorous 0.8 mmol/l. HIV serology was negative. A retrospective measurement of calcium at 14 weeks' gestation was obtained at 2.43 mmol/l. Liver function test: ALT 4 u/l, AST 11 u/l, ALP 150 u/l, total protein 72 g/l, and albumen 30 g/l. Lipid profile: cholesterol 4.05 mmol/l and triglyceride 3.59 mmol/l. Hormone study: PTH 3 pg/ml (normal:15-65), TSH 0.68 mIU/l (normal: 0.45-4.5), free thyroxin 16.6 pmol/l (normal: 9-20), cortisol 1849 nmol/l, and vitamin D 15 ng/ml (normal: 30-80). Serum protein electrophoresis as well as serum level of angiotensin-converting enzyme were normal.

In consultation with the internist, the patient was given normal saline infusion at 250 ml/h with close monitoring of her urine output plus intramuscular calcitonin, and she was transferred to the medical intensive care unit.

Based on these laboratory findings, the possible diagnosis was humoral hypercalcemia of benignancy (uterine fibroid). PTH-rP is the primary mediator that causes hypercalcemia. However, we did not check for the PTH-rP level because of lack of facilities.

In the intensive care unit, the patient developed rupture membrane, which entailed urgent cesarean section while calcium remained high. However, because of hypercalcemia and reduction in the urine output with a rise in serum creatinine, the nephrologist was consulted for urgent hemodialysis before the operation. The surgery was complicated by bleeding, leading to hypotension requiring blood transfusion despite the successful delivery of a baby girl weighing 2.9 kg and removal of uterine masses measuring in aggregate 30 × 25 × 15 cm, which were submitted to a histopathological examination and the histopathology report was consistent with leiomyoma with calcifications but no evidence of malignancy. The postoperative clinical course was further complicated by septicemia and septic shock, which required vasopressors and broad-spectrum antibiotics.

Postoperative laboratory test results were as follows: serum calcium 2.34 mmol/l, phosphorus 1.1 mmol/l, BUN 6.2 mmol/l, Cr 75 mmol/l, Na 143 mmol/l, K 4.2 mmol/l, HCO 3 16 mEq/l, chloride 113 mEq/l, albumin 21 g/l, serum lactate 5.19, serum PTH 155 pg/ml, serum amylase 88 u/l, serum lipase 73 u/l; Hb 5.8 g/dl, platelets 125 000 μl 1 . The CT scan of the chest and pelvis showed no evidence of mass lesion or organomegaly. MRI of the brain that was done because of the deterioration in the level of consciousness showed evidence of infarcts involving the right cerebellum, the lentiform nucleus on both sides, as well as the cortical regions in frontal, parietal, and occipital lobes. MRA revealed evidence of vasospasm of the internal carotid, the middle and the anterior carotid arteries; the findings are suggestive of diffuse ischemic changes secondary to hypoxic insult. Subsequently, her condition began to improve but her neurological status required extensive physiotherapy for the generalized muscle weakness and stiffness. The patient was discharged home, with a final diagnosis of humoral hypercalcemia associated with a uterine fibroid. Serum calcium remained within the normal range over the subsequent 6 months [Figure 1].
Figure 1: Calcium level during pregnancy, after delivery, and 6 months after delivery

Click here to view



   Discussion Top


PTH-rP was discovered in 1987 by Mosley et al as a tumor-derived factor that caused humoral hypercalcemia of malignancy. Breast, lung, ovarian, renal cell carcinomas, lymphoma, and multiple myeloma are the malignancies that are most commonly associated with humoral hypercalcemia. Although extremely rare, hypercalcemias due to high serum levels of PTH-rP in the setting of benign disease (humoral hypercalcemia of benignancy) have been reported. [1],[3],[4],[5],[6],[7],[8]

PTH-rP has been identified in the normal tissue of the reproductive tract. It is thought to be important during late pregnancy and lactation. The exact function is unknown, but it has been postulated that it may cause vasodilatation and smooth muscle relaxation and may be involved in the rhythmicity of myometrial contractions before parturition.

In our patient, although PTH-rP was not assessed due to lack of facilities, hypercalcemia was attributed to humoral hypercalcemia associated with a uterine fibroid, since other causes of hypercalcemia such as primary hyperparathyroidism, vitamin A and D intoxication, sarcoidosis, multiple myeloma, milk-alkali syndrome, adrenal insufficiency, and immobilization were excluded on the basis of laboratory and clinical data.

Our patient had low level of PTH, which was attributed to suppression of secretion by increased levels of serum calcium, whereas postoperative PTH was high, reflecting rebound hyperparathyroidism due to rapid normalization of calcium level by hemodialysis.

The most common symptoms of hypercalcemia are weakness, fatigue, nausea, vomiting, anorexia, and headaches. [2] On the other hand, the patient in hypercalcemic crisis defined as serum calcium levels above 3.5 mmol/l may present with anorexia, protracted vomiting, depression, proximal muscle weakness, constipation, osteopenia, confusion, hypertension, nephrolithiasis, pancreatitis, and coma. [2] Our patient was in hypercalcemic crisis and presented with recurrent vomiting and epigastric pain.

The treatment of hypercalcemia depends on the level, the chronicity, and the underlying cause of the problem. Hypercalcemic crisis in pregnancy is a potentially life-threatening condition that needs prompt intervention. The main aspects of treatment include adequate hydration and correction of electrolyte abnormalities. Pharmacologic agents to treat hypercalcemia have not been adequately studied in pregnancy. Calcitonin does not cross the placenta and has been used safely. Oral phosphate has also been used but is limited by diarrhea, hypokalemia, and risk of soft tissue calcifications. Bisphosphonates and mithramycin are contraindicated because of their adverse effects on fetal development. Our patient needed urgent cesarean section; therefore, hemodialysis was carried out to treat hypercalcemia.


   Conclusion Top


Humoral hypercalcemia is a well-recognized complication of uterine fibroid that should be considered in differential diagnosis of hypercalcemia in a pregnant woman who had a uterine fibroid.

 
   References Top

1.Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: Review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr J 2008;55:959-66.   Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Mestman JH. Parathyroid disorders of pregnancy. Semin Perinatol 1998;22:485-96.   Back to cited text no. 2
[PUBMED]    
3.Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, et al. Parathyroid hormone related protein and hypercalcaemia secondary to massive mammary hyperplasia. N Engl J Med 1990;322:1157.  Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.Ravakhah K, Gover A, Mukunda BN. Humoral hypercalcaemia associated with uterine fibroid. Ann Intern Med 1999;130:702.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.Kimura S, Nishimura Y, Yamaguchi K, Shmada K, Uchida H. A case of pheochromocytoma producing parathyroid hormone related protein and presenting with hypercalcaemia. J Clin Endocrinol Metab 1990;70:1559-63.  Back to cited text no. 5
    
6.Herring R, Laji K. Humoral hypercalcaemia of benignancy. A case report. QJM 2008;101:329-30.  Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Dagdelen S, Kalan I, Gurlek A. Humoral hypercalcemia of benignancy secondary to parathyroid hormone-related protein secreting uterine leiomyoma. Am J Med Sci 2008;335:407-8.  Back to cited text no. 7
[PUBMED]  [FULLTEXT]  
8.Bilici A, Doventas A, Karadag B, Hekim N, Tezcan V. Hypercalcemia associated with a uterine leiomyoma: A case report and review of the literature. Gynecol Oncol 2004;93:269-71.  Back to cited text no. 8
[PUBMED]  [FULLTEXT]  

Top
Correspondence Address:
Fahmi Yousef Khan
Department of Medicine, Hamad General Hospital, Doha
Qatar
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2700.93093

Rights and Permissions


    Figures

  [Figure 1]

This article has been cited by
1 Desensitization properties of P2X3 receptors shaping pain signaling
Authors of Document Giniatullin, R., Nistri, A.
Frontiers in Cellular Neuroscience. 2013;
[Pubmed]



 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Case Report
   Discussion
   Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed2736    
    Printed146    
    Emailed2    
    PDF Downloaded18    
    Comments [Add]    
    Cited by others 1    

Recommend this journal